Zobrazeno 1 - 10
of 349
pro vyhledávání: '"Jonathan S. Serody"'
Autor:
Sonia J. Laurie, Joseph P. Foster, Danny W. Bruce, Hemamalini Bommiasamy, Oleg V. Kolupaev, Mostafa Yazdimamaghani, Samantha G. Pattenden, Nelson J. Chao, Stefanie Sarantopoulos, Joel S. Parker, Ian J. Davis, Jonathan S. Serody
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Type II innate lymphoid cells (ILC2s) maintain homeostasis and barrier integrity in mucosal tissues. In both mice and humans, ILC2s poorly reconstitute after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Determining the mec
Externí odkaz:
https://doaj.org/article/deafa590173041a485a51c32ab3e3f46
Autor:
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P. Vensko, Mark G. Woodcock, Hsing-Hui Wang, Sara E. Wobker, Gatphan Atassi, Alec D. Wilkinson, Kenneth Fowler, Leah M. Flick, Jeffrey S. Damrauer, Michael R. Harrison, Karen P. McKinnon, Tracy L. Rose, Matthew I. Milowsky, Jonathan S. Serody, William Y. Kim, Benjamin G. Vincent
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Neoadjuvant cisplatin-based chemotherapy is standard of care for muscle-invasive bladder cancer (MIBC). Immune checkpoint inhibition (ICI) alone, and ICI in combination with chemotherapy, have demonstrated promising pathologic response (
Externí odkaz:
https://doaj.org/article/20a284baf2454780aedd68c631ea83b7
Autor:
Barbara Savoldo, Gianpietro Dotti, Allison M Deal, Jonathan S Serody, Christopher Dittus, Nicholas P Tschernia, Hillary Heiling, Catherine Cheng, Caroline Babinec, Megan Gonzalez, J Kaitlin Morrison, Anne W Beaven, William A Wood, Natalie S Grover
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Chimeric antigen receptor (CAR)-T cells targeting CD30 have demonstrated high response rates with durable remissions observed in a subset of patients with relapsed/refractory CD30+ hematologic malignancies, particularly classical Hodgkin lymphoma. Th
Externí odkaz:
https://doaj.org/article/37ff0a870b1541c7ae281d7f0e1e2333
Autor:
Mark G Woodcock, Benjamin G Vincent, Jonathan S Serody, Eric D Routh, Wolfgang Beckabir, Steven P Vensko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
The role of B cells in antitumor immunity is becoming increasingly appreciated, as B cell populations have been associated with response to immune checkpoint blockade (ICB) in patients with breast cancer and murine models of breast cancer. Deeper und
Externí odkaz:
https://doaj.org/article/a3b711a78b764fab9e0bfd98e60e96be
Autor:
Hsuan Su, Kazuhiro Imai, Wei Jia, Zhiguo Li, Rachel A. DiCioccio, Jonathan S. Serody, Jonathan C. Poe, Benny J. Chen, Phuong L. Doan, Stefanie Sarantopoulos
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
De novo immune responses to myeloid and other blood-borne tumors are notably limited and ineffective, making our ability to promote immune responses with vaccines a major challenge. While focus has been largely on cytotoxic cell-mediated tumor eradic
Externí odkaz:
https://doaj.org/article/e5191fc99d69408f89ec5efebfa81933
Autor:
Ranganatha R. Somasagara, Xiaoyan Huang, Chunyu Xu, Jamil Haider, Jonathan S. Serody, Paul M. Armistead, TinChung Leung
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Personalized medicine holds tremendous promise for improving safety and efficacy of drug therapies by optimizing treatment regimens. Rapidly developed patient-derived xenografts (pdx) could be a helpful tool for analyzing the effect of drugs
Externí odkaz:
https://doaj.org/article/ca05924fb6f54487b4ff2e4948c6d8d3
Autor:
Karen McKinnon, Kristen Cowens, Dante Bortone, Lisa Carey, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, Carey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A Cuaboy, Amy L Garrett, Benjamin C Calhoun, Alec D Wilkinson, E Claire Dees, Benjamin G Vincent, Jonathan S Serody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/4b4477f689454bc2b5fe6bd317c412e0
Autor:
Benjamin G. Vincent, Danielle M. File, Karen P. McKinnon, Dominic T. Moore, Jeffrey A. Frelinger, Edward J. Collins, Joseph G. Ibrahim, Lisa Bixby, Shannon Reisdorf, Sonia J. Laurie, Yara A. Park, Carey K. Anders, Frances A. Collichio, Hyman B. Muss, Lisa A. Carey, Hendrik W. van Deventer, E. Claire Dees, Jonathan S. Serody
Publikováno v:
J Immunol
Previous work from our group and others has shown that patients with breast cancer can generate a T cell response against specific human epidermal growth factor 2 (HER2) epitopes. In addition, preclinical work has shown that this T cell response can
Autor:
Benjamin G. Vincent, Jonathan S. Serody, Barbara Savoldo, Joel S. Parker, Sara R. Selitsky, Lisa M. Bixby, Jason Garness, Kevin Field, Elisa Landoni, Samuel J. Lee, Amber R. Washington, Shengjie Chai, Christof C. Smith
Supplemental Data File
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df27d3056d30beca5fd660ccccf851d
https://doi.org/10.1158/2326-6066.22542117
https://doi.org/10.1158/2326-6066.22542117
Autor:
Ivana Gojo, Jonathan S. Serody, Leo Luznik, Nathan D. Montgomery, Mark J. Levis, B. Douglas Smith, Amy E. DeZern, Gabrielle T. Prince, Jonathan A. Webster, Hendrik Van Deventer, Katarzyna Jamieson, Catherine C. Coombs, Matthew C. Foster, Hanna A. Knaus, Francesco Mazziotta, Rupkatha Mukhopadhyay, Alec D. Wilkinson, Karen P. McKinnon, Dominic Moore, Anastasia Ivanova, Benjamin G. Vincent, Joshua F. Zeidner
Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574ae48df49e97c2a4bc9c7170265627
https://doi.org/10.1158/2643-3230.22543396.v1
https://doi.org/10.1158/2643-3230.22543396.v1